Zobrazeno 1 - 10
of 24
pro vyhledávání: '"I. K. Taylor"'
Autor:
I K Taylor
Publikováno v:
Thorax. 50:1005-1010
Autor:
Douglas S. Robinson, R. J. Shaw, D. M. Mitchell, I K Taylor, A. B. Kay, Qutayba Hamid, Sun Ying, A. Wangoo
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 149:989-993
Mycobacterium-specific human helper T-cell clones produce a Th1 pattern of cytokines in vitro: interferon-gamma (IFN-gamma) and interleukin-2 (IL-2), but little or no IL-4 or IL-5. To test the hypothesis that a similar Th1-like pattern of cytokine ge
Publikováno v:
Thorax. 48:1222-1226
BACKGROUND--HIV is present in bronchoalveolar lavage cells of some but not all HIV seropositive patients. Abnormalities of lung function have been described in such patients in the absence of clinically overt pneumonia or other respiratory infections
Publikováno v:
European Respiratory Journal. 5:712-716
Glucocorticosteroids are used as anti-inflammatory agents in a range of diseases, however, their mechanism of action is unknown. Recently, inhibition of arachidonic acid metabolism has been suggested as one possible mechanism of action. A series of e
Autor:
I. K. Taylor, R.W. Fuller, James B.D. Palmer, Kevin M. O'Shaughnessy, Mitsuru Adachi, Nozhat B. Choudry
Publikováno v:
Journal of Allergy and Clinical Immunology. 89:575-583
Salmeterol (SM) is a novel β 2 -adrenoceptor agonist with a duration of action in excess of 12 hours. Evidence from in vitro studies has also demonstrated that, unlike the short-acting β 2 -agonists, such as salbutamol (SB), it may have some anti-i
Publikováno v:
The Lancet. 337:690-694
The effects of a highly selective leukotriene D4 receptor antagonist, ICI 204.219, on allergen-induced bronchoconstriction and changes in airway reactivity were evaluated in a double-blind, placebo-controlled, crossover trial. Ten atopic subjects wer
Autor:
R.W. Fuller, Peter Black, Paul S. Ward, I. K. Taylor, Graham W. Taylor, Colin T. Dollery, S.E. Barrow, Kevin M. O'Shaughnessy
Publikováno v:
American Review of Respiratory Disease. 143:119-125
Thromboxane A2 is a potent bronchial smooth muscle spasmogen in vitro, and it has been implicated in airway inflammation and in the genesis of bronchial hyperresponsiveness in asthma. We have examined the urinary excretion of a variety of products de
Autor:
R. B. Nieman, F M Moss, Richard Coker, I K Taylor, John R. Clarke, Douglas S. Robinson, R J Shaw, D. Veale, D J Evans, D M Mitchell
BACKGROUND--Pulmonary disease is a major contributor to morbidity and mortality in patients with HIV infection and AIDS. The aim of this study was to describe bronchoscopic findings and the spectrum of pulmonary pathogens in HIV seropositive patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8666a2b82d39eac55c1ce91cf99d73a0
https://europepmc.org/articles/PMC1021344/
https://europepmc.org/articles/PMC1021344/
BACKGROUND--Although the causes of the worldwide resurgence of tuberculosis are multifactorial, the HIV epidemic is believed to have had a central role. Control is further threatened by the emergence of multidrug-resistant tuberculosis. METHODS--A re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c1dc137d33835efc2f9d056de97c00
https://europepmc.org/articles/PMC475085/
https://europepmc.org/articles/PMC475085/
Publikováno v:
Pulmonary pharmacology. 7(6)
The macrophage profibrotic cytokine, Platelet Derived Growth Factor B [PDGF(B)], is thought to play a central role in orchestrating the fibrotic response in the pathogenesis of cryptogenic fibrosing alveolitis. In this study, we have asked if drugs t